+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cholera Vaccines Market Size, Share & Analysis Report By Type (Whole cell V. Cholerae O1 Recombinant With B-Subunit), By Product (Vaxchora, Dukoral), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy), By Region, And Segment Forecasts, 2025 - 2030- Product Image
Cholera Vaccines Market Size, Share & Analysis Report By Type (Whole cell V. Cholerae O1 Recombinant With B-Subunit), By Product (Vaxchora, Dukoral), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy), By Region, And Segment Forecasts, 2025 - 2030- Product Image
New

Cholera Vaccines Market Size, Share & Analysis Report By Type (Whole cell V. Cholerae O1 Recombinant With B-Subunit), By Product (Vaxchora, Dukoral), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy), By Region, And Segment Forecasts, 2025 - 2030

  • PDF Icon

    Report

  • 100 Pages
  • November 2024
  • Region: Global
  • Grand View Research
  • ID: 6032383
Description Jump to:
The global cholera vaccines market size is expected to reach USD 163.4 million by 2030, exhibiting a CAGR of 10.0% from 2025 to 2030. Increase in number of initiatives and rising awareness about cholera are major factors contributing toward market growth.

Governments in regions affected by cholera are striving to eliminate the disease by developing a strong public health and sanitation infrastructure. In February 2013, the Government of Haiti launched a 10-year National Cholera Elimination Plan. The United Nations Organization has made elimination of cholera a key UN priority and offers support to the Haitian Government by establishing a mechanism to respond to an alert within 48 hours, household visits, and sensitization campaigns.

Furthermore, various research projects and studies, such as epidemiological and anthropological studies, are being conducted in Africa. Ongoing studies include using rapid diagnostics tests to detect Vibrio cholerae in samples of water to understand epidemic diffusion mechanisms and anticipate outbreaks. The Cholera Platform is working with the Global Task Force for Cholera Control (GTFCC) WASH working group. This association aims to develop a method for conducting case studies to control and prevent the disease.

Cholera Vaccines Market Report Highlights

  • The global cholera vaccine market size was valued at USD 93.9 million in 2024 and is anticipated to grow at a CAGR of 10.0% from 2025 to 2030
  • By product, Dukoral vaccine dominated the market in 2024. The dominance can be attributed to the positive outcomes of this vaccine in preventing the disease since 2004. Dukoral is considered to be safe and stable
  • The Vaxchora segment is expected to exhibit a lucrative CAGR over the forecast period owing to benefits associated with the vaccine, such as single dose immunization and reduced adverse effects
  • North America held the largest share in 2024 due to factors such as increasing incidence and growing initiatives for raising awareness about the disease and vaccination

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players worldwide.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Cholera Vaccine Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Cholera Vaccine Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining Power of the Suppliers
3.4.1.2. Bargaining Power of the Buyers
3.4.1.3. Threats of Substitution
3.4.1.4. Threats from New Entrants
3.4.1.5. Competitive Rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political Landscape
3.4.2.2. Economic and Social Landscape
3.4.2.3. Technological Landscape
3.4.2.4. Environmental Landscape
3.4.2.5. Legal Landscape
Chapter 4. Cholera Vaccine Market: Type Estimates & Trend Analysis
4.1. Type Market Share, 2024 & 2030
4.2. Type Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
4.4. Whole Cell V. Cholerae O1 with Recombinant B-subunit
4.4.1. Whole Cell V. Cholerae O1 with Recombinant B-subunit Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Killed Oral O1 and O139
4.5.1. Killed Oral O1 and O139 Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Cholera Vaccine Market: Product Estimates & Trend Analysis
5.1. Product Market Share, 2024 & 2030
5.2. Product Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
5.4. Vaxchora
5.4.1. Vaxchora Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Dukoral
5.5.1. Dukoral Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Shanchol
5.6.1. Shanchol Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Other Products
5.7.1. Other Products Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Cholera Vaccine Market: Distribution Channel Estimates & Trend Analysis
6.1. Distribution Channel Market Share, 2024 & 2030
6.2. Distribution Channel Segment Dashboard
6.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2018 to 2030 (USD Million)
6.4. Hospital Pharmacy
6.4.1. Hospital Pharmacy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Retail Pharmacy
6.5.1. Retail Pharmacy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Others
6.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Cholera Vaccine Market: Regional Estimates & Trend Analysis
7.1. Regional Market Share Analysis, 2024 & 2030
7.2. Regional Market Dashboard
7.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
7.4. North America
7.4.1. North America Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.2. U.S.
7.4.2.1. Key Country Dynamics
7.4.2.2. Regulatory Framework
7.4.2.3. Competitive Insights
7.4.2.4. U.S. Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.3. Canada
7.4.3.1. Key Country Dynamics
7.4.3.2. Regulatory Framework
7.4.3.3. Competitive Insights
7.4.3.4. Canada Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.4. Mexico
7.4.4.1. Key Country Dynamics
7.4.4.2. Regulatory Framework
7.4.4.3. Competitive Insights
7.4.4.4. Mexico Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Europe
7.5.1. Europe Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.2. UK
7.5.2.1. Key Country Dynamics
7.5.2.2. Regulatory Framework
7.5.2.3. Competitive Insights
7.5.2.4. UK Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.3. Germany
7.5.3.1. Key Country Dynamics
7.5.3.2. Regulatory Framework
7.5.3.3. Competitive Insights
7.5.3.4. Germany Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.4. France
7.5.4.1. Key Country Dynamics
7.5.4.2. Regulatory Framework
7.5.4.3. Competitive Insights
7.5.4.4. France Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.5. Italy
7.5.5.1. Key Country Dynamics
7.5.5.2. Regulatory Framework
7.5.5.3. Competitive Insights
7.5.5.4. Italy Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.6. Spain
7.5.6.1. Key Country Dynamics
7.5.6.2. Regulatory Framework
7.5.6.3. Competitive Insights
7.5.6.4. Spain Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.7. Denmark
7.5.7.1. Key Country Dynamics
7.5.7.2. Regulatory Framework
7.5.7.3. Competitive Insights
7.5.7.4. Denmark Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.8. Sweden
7.5.8.1. Key Country Dynamics
7.5.8.2. Regulatory Framework
7.5.8.3. Competitive Insights
7.5.8.4. Sweden Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.9. Norway
7.5.9.1. Key Country Dynamics
7.5.9.2. Regulatory Framework
7.5.9.3. Competitive Insights
7.5.9.4. Norway Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Asia Pacific
7.6.1. Asia Pacific Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.2. China
7.6.2.1. Key Country Dynamics
7.6.2.2. Regulatory Framework
7.6.2.3. Competitive Insights
7.6.2.4. China Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.3. Japan
7.6.3.1. Key Country Dynamics
7.6.3.2. Regulatory Framework
7.6.3.3. Competitive Insights
7.6.3.4. Japan Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.4. India
7.6.4.1. Key Country Dynamics
7.6.4.2. Regulatory Framework
7.6.4.3. Competitive Insights
7.6.4.4. India Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.5. Australia
7.6.5.1. Key Country Dynamics
7.6.5.2. Regulatory Framework
7.6.5.3. Competitive Insights
7.6.5.4. Australia Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.6. South Korea
7.6.6.1. Key Country Dynamics
7.6.6.2. Regulatory Framework
7.6.6.3. Competitive Insights
7.6.6.4. South Korea Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.7. Thailand
7.6.7.1. Key Country Dynamics
7.6.7.2. Regulatory Framework
7.6.7.3. Competitive Insights
7.6.7.4. Thailand Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7. Latin America
7.7.1. Latin America Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7.2. Brazil
7.7.2.1. Key Country Dynamics
7.7.2.2. Regulatory Framework
7.7.2.3. Competitive Insights
7.7.2.4. Brazil Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7.3. Argentina
7.7.3.1. Key Country Dynamics
7.7.3.2. Regulatory Framework
7.7.3.3. Competitive Insights
7.7.3.4. Argentina Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8. Middle East and Africa
7.8.1. Middle East and Africa Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8.2. South Africa
7.8.2.1. Key Country Dynamics
7.8.2.2. Regulatory Framework
7.8.2.3. Competitive Insights
7.8.2.4. South Africa Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8.3. Saudi Arabia
7.8.3.1. Key Country Dynamics
7.8.3.2. Regulatory Framework
7.8.3.3. Competitive Insights
7.8.3.4. Saudi Arabia Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8.4. UAE
7.8.4.1. Key Country Dynamics
7.8.4.2. Regulatory Framework
7.8.4.3. Competitive Insights
7.8.4.4. UAE Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8.5. Kuwait
7.8.5.1. Key Country Dynamics
7.8.5.2. Regulatory Framework
7.8.5.3. Competitive Insights
7.8.5.4. Kuwait Cholera Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Participant Overview
8.2. Company Market Position Analysis
8.3. Company Categorization
8.4. Strategy Mapping
8.5. Company Profiles/Listing
8.5.1. Valneva SE
8.5.1.1. Participant’s Overview
8.5.1.2. Financial Performance
8.5.1.3. Product Benchmarking
8.5.1.4. Recent Developments/ Strategic Initiatives
8.5.2. Sanofi S.A.
8.5.2.1. Participant’s Overview
8.5.2.2. Financial Performance
8.5.2.3. Product Benchmarking
8.5.2.4. Recent Developments/ Strategic Initiatives
8.5.3. Emergent BioSolutions Inc.
8.5.3.1. Participant’s Overview
8.5.3.2. Financial Performance
8.5.3.3. Product Benchmarking
8.5.3.4. Recent Developments/ Strategic Initiatives
8.5.4. PaxVax Inc.
8.5.4.1. Participant’s Overview
8.5.4.2. Financial Performance
8.5.4.3. Product Benchmarking
8.5.4.4. Recent Developments/ Strategic Initiatives
8.5.5. EuBiologics Co., Ltd.
8.5.5.1. Participant’s Overview
8.5.5.2. Financial Performance
8.5.5.3. Product Benchmarking
8.5.5.4. Recent Developments/ Strategic Initiatives
8.5.6. Shantha Biotechnics Limited
8.5.6.1. Participant’s Overview
8.5.6.2. Financial Performance
8.5.6.3. Product Benchmarking
8.5.6.4. Recent Developments/ Strategic Initiatives
8.5.7. Hilleman Laboratories
8.5.7.1. Participant’s Overview
8.5.7.2. Financial Performance
8.5.7.3. Product Benchmarking
8.5.7.4. Recent Developments/ Strategic Initiatives
8.5.8. Astellas Pharma Inc.
8.5.8.1. Participant’s Overview
8.5.8.2. Financial Performance
8.5.8.3. Product Benchmarking
8.5.8.4. Recent Developments/ Strategic Initiatives
8.5.9. Incepta Vaccine Ltd.
8.5.9.1. Participant’s Overview
8.5.9.2. Financial Performance
8.5.9.3. Product Benchmarking
8.5.9.4. Recent Developments/ Strategic Initiatives
8.5.10. Vabiotech
8.5.10.1. Participant’s Overview
8.5.10.2. Financial Performance
8.5.10.3. Product Benchmarking
8.5.10.4. Recent Developments/ Strategic Initiatives
List of Tables
Table 1. List of Secondary Sources
Table 2. List of Abbreviations
Table 3. Global Cholera Vaccine Market, by Region, 2018 - 2030 (USD Million)
Table 4. Global Cholera Vaccine Market, by Type, 2018 - 2030 (USD Million)
Table 5. Global Cholera Vaccine Market, by Product, 2018 - 2030 (USD Million)
Table 6. Global Cholera Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 7. North America Cholera Vaccine Market, by Country, 2018 - 2030 (USD Million)
Table 8. North America Cholera Vaccine Market, by Type, 2018 - 2030 (USD Million)
Table 9. North America Cholera Vaccine Market, by Product, 2018 - 2030 (USD Million)
Table 10. North America Cholera Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 11. U.S. Cholera Vaccine Market, by Type, 2018 - 2030 (USD Million)
Table 12. U.S. Cholera Vaccine Market, by Product, 2018 - 2030 (USD Million)
Table 13. U.S. Cholera Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 14. Canada Cholera Vaccine Market, by Type, 2018 - 2030 (USD Million)
Table 15. Canada Cholera Vaccine Market, by Product, 2018 - 2030 (USD Million)
Table 16. Canada Cholera Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 17. Mexico Cholera Vaccine Market, by Type, 2018 - 2030 (USD Million)
Table 18. Mexico Cholera Vaccine Market, by Product, 2018 - 2030 (USD Million)
Table 19. Mexico Cholera Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 20. Europe Cholera Vaccine Market, by Country, 2018 - 2030 (USD Million)
Table 21. Europe Cholera Vaccine Market, by Type, 2018 - 2030 (USD Million)
Table 22. Europe Cholera Vaccine Market, by Product, 2018 - 2030 (USD Million)
Table 23. Europe Cholera Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 24. UK Cholera Vaccine Market, by Type, 2018 - 2030 (USD Million)
Table 25. UK Cholera Vaccine Market, by Product, 2018 - 2030 (USD Million)
Table 26. UK Cholera Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 27. Germany Cholera Vaccine Market, by Type, 2018 - 2030 (USD Million)
Table 28. Germany Cholera Vaccine Market, by Product, 2018 - 2030 (USD Million)
Table 29. Germany Cholera Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 30. France Cholera Vaccine Market, by Type, 2018 - 2030 (USD Million)
Table 31. France Cholera Vaccine Market, by Product, 2018 - 2030 (USD Million)
Table 32. France Cholera Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 33. Italy Cholera Vaccine Market, by Type, 2018 - 2030 (USD Million)
Table 34. Italy Cholera Vaccine Market, by Product, 2018 - 2030 (USD Million)
Table 35. Italy Cholera Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 36. Spain Cholera Vaccine Market, by Type, 2018 - 2030 (USD Million)
Table 37. Spain Cholera Vaccine Market, by Product, 2018 - 2030 (USD Million)
Table 38. Spain Cholera Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 39. Denmark Cholera Vaccine Market, by Type, 2018 - 2030 (USD Million)
Table 40. Denmark Cholera Vaccine Market, by Product, 2018 - 2030 (USD Million)
Table 41. Denmark Cholera Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 42. Sweden Cholera Vaccine Market, by Type, 2018 - 2030 (USD Million)
Table 43. Sweden Cholera Vaccine Market, by Product, 2018 - 2030 (USD Million)
Table 44. Sweden Cholera Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 45. Norway Cholera Vaccine Market, by Type, 2018 - 2030 (USD Million)
Table 46. Norway Cholera Vaccine Market, by Product, 2018 - 2030 (USD Million)
Table 47. Norway Cholera Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 48. Asia Pacific Cholera Vaccine Market, by Country, 2018 - 2030 (USD Million)
Table 49. Asia Pacific Cholera Vaccine Market, by Type, 2018 - 2030 (USD Million)
Table 50. Asia Pacific Cholera Vaccine Market, by Product, 2018 - 2030 (USD Million)
Table 51. Asia Pacific Cholera Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 52. Japan Cholera Vaccine Market, by Type, 2018 - 2030 (USD Million)
Table 53. Japan Cholera Vaccine Market, by Product, 2018 - 2030 (USD Million)
Table 54. Japan Cholera Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 55. China Cholera Vaccine Market, by Type, 2018 - 2030 (USD Million)
Table 56. China Cholera Vaccine Market, by Product, 2018 - 2030 (USD Million)
Table 57. China Cholera Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 58. India Cholera Vaccine Market, by Type, 2018 - 2030 (USD Million)
Table 59. India Cholera Vaccine Market, by Product, 2018 - 2030 (USD Million)
Table 60. India Cholera Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 61. Australia Cholera Vaccine Market, by Type, 2018 - 2030 (USD Million)
Table 62. Australia Cholera Vaccine Market, by Product, 2018 - 2030 (USD Million)
Table 63. Australia Cholera Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 64. South Korea Cholera Vaccine Market, by Type, 2018 - 2030 (USD Million)
Table 65. South Korea Cholera Vaccine Market, by Product, 2018 - 2030 (USD Million)
Table 66. South Korea Cholera Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 67. Thailand Cholera Vaccine Market, by Type, 2018 - 2030 (USD Million)
Table 68. Thailand Cholera Vaccine Market, by Product, 2018 - 2030 (USD Million)
Table 69. Thailand Cholera Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 70. Latin America Cholera Vaccine Market, by Country, 2018 - 2030 (USD Million)
Table 71. Latin America Cholera Vaccine Market, by Type, 2018 - 2030 (USD Million)
Table 72. Latin America Cholera Vaccine Market, by Product, 2018 - 2030 (USD Million)
Table 73. Latin America Cholera Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 74. Brazil Cholera Vaccine Market, by Type, 2018 - 2030 (USD Million)
Table 75. Brazil Cholera Vaccine Market, by Product, 2018 - 2030 (USD Million)
Table 76. Brazil Cholera Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 77. Argentina Cholera Vaccine Market, by Type, 2018 - 2030 (USD Million)
Table 78. Argentina Cholera Vaccine Market, by Product, 2018 - 2030 (USD Million)
Table 79. Argentina Cholera Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 80. Middle East & Africa Cholera Vaccine Market, by Country, 2018 - 2030 (USD Million)
Table 81. Middle East & Africa Cholera Vaccine Market, by Type, 2018 - 2030 (USD Million)
Table 82. Middle East & Africa Cholera Vaccine Market, by Product, 2018 - 2030 (USD Million)
Table 83. Middle East & Africa Cholera Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 84. South Africa Cholera Vaccine Market, by Type, 2018 - 2030 (USD Million)
Table 85. South Africa Cholera Vaccine Market, by Product, 2018 - 2030 (USD Million)
Table 86. South Africa Cholera Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 87. Saudi Arabia Cholera Vaccine Market, by Type, 2018 - 2030 (USD Million)
Table 88. Saudi Arabia Cholera Vaccine Market, by Product, 2018 - 2030 (USD Million)
Table 89. Saudi Arabia Cholera Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 90. UAE Cholera Vaccine Market, by Type, 2018 - 2030 (USD Million)
Table 91. UAE Cholera Vaccine Market, by Product, 2018 - 2030 (USD Million)
Table 92. UAE Cholera Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 93. Kuwait Cholera Vaccine Market, by Type, 2018 - 2030 (USD Million)
Table 94. Kuwait Cholera Vaccine Market, by Product, 2018 - 2030 (USD Million)
Table 95. Kuwait Cholera Vaccine Market, by Distribution Channel, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Cholera Vaccine Market Segmentation
Fig. 2 Market Research Process
Fig. 3 Data Triangulation Techniques
Fig. 4 Primary Research Pattern
Fig. 5 Market Research Approaches
Fig. 6 Value Chain-Based Sizing & Forecasting
Fig. 7 Market Formulation & Validation
Fig. 8 Market Snapshot
Fig. 9 Segment Outlook (USD Million)
Fig. 10 Competitive Landscape
Fig. 11 Cholera Vaccine Market Dynamics
Fig. 12 Cholera Vaccine Market: Porter’s Five Forces Analysis
Fig. 13 Cholera Vaccine Market: Pestle Analysis
Fig. 14 Cholera Vaccine Market: Type Segment Dashboard
Fig. 15 Cholera Vaccine Market: Type Market Share Analysis, 2024 & 2030
Fig. 16 Whole Cell V. Cholerae O1 with Recombinant B-subunit (USD Million)
Fig. 17 Killed Oral O1 and O139 (USD Million)
Fig. 18 Cholera Vaccine Market: Product Segment Dashboard
Fig. 19 Cholera Vaccine Market: Product Market Share Analysis, 2024 & 2030
Fig. 20 Vaxchora Market, 2018 - 2030 (USD Million)
Fig. 21 Dukoral Market, 2018 - 2030 (USD Million)
Fig. 22 Shanchol Market, 2018 - 2030 (USD Million)
Fig. 23 Other Products Market, 2018 - 2030 (USD Million)
Fig. 24 Cholera Vaccine Market: Distribution Channel Segment Dashboard
Fig. 25 Cholera Vaccine Market: Distribution Channel Market Share Analysis, 2024 & 2030
Fig. 26 Hospital Pharmacy Market, 2018 - 2030 (USD Million)
Fig. 27 Retail Pharmacy Market, 2018 - 2030 (USD Million)
Fig. 28 Others Market, 2018 - 2030 (USD Million)
Fig. 29 Regional Marketplace: Key Takeaways
Fig. 30 North America Cholera Vaccine Market, 2018 - 2030 (USD Million)
Fig. 31 U.S. Country Dynamics
Fig. 32 U.S. Cholera Vaccine Market, 2018 - 2030 (USD Million)
Fig. 33 Canada Country Dynamics
Fig. 34 Canada Cholera Vaccine Market, 2018 - 2030 (USD Million)
Fig. 35 Mexico Country Dynamics
Fig. 36 Mexico Cholera Vaccine Market, 2018 - 2030 (USD Million)
Fig. 37 Europe Cholera Vaccine Market, 2018 - 2030 (USD Million)
Fig. 38 UK Country Dynamics
Fig. 39 UK Cholera Vaccine Market, 2018 - 2030 (USD Million)
Fig. 40 Germany Country Dynamics
Fig. 41 Germany Cholera Vaccine Market, 2018 - 2030 (USD Million)
Fig. 42 France Country Dynamics
Fig. 43 France Cholera Vaccine Market, 2018 - 2030 (USD Million)
Fig. 44 Italy Country Dynamics
Fig. 45 Italy Cholera Vaccine Market, 2018 - 2030 (USD Million)
Fig. 46 Spain Country Dynamics
Fig. 47 Spain Cholera Vaccine Market, 2018 - 2030 (USD Million)
Fig. 48 Denmark Country Dynamics
Fig. 49 Denmark Cholera Vaccine Market, 2018 - 2030 (USD Million)
Fig. 50 Sweden Country Dynamics
Fig. 51 Sweden Cholera Vaccine Market, 2018 - 2030 (USD Million)
Fig. 52 Norway Country Dynamics
Fig. 53 Norway Cholera Vaccine Market, 2018 - 2030 (USD Million)
Fig. 54 Asia Pacific Cholera Vaccine Market, 2018 - 2030 (USD Million)
Fig. 55 Japan Country Dynamics
Fig. 56 Japan Cholera Vaccine Market, 2018 - 2030 (USD Million)
Fig. 57 China Country Dynamics
Fig. 58 China Cholera Vaccine Market, 2018 - 2030 (USD Million)
Fig. 59 India Country Dynamics
Fig. 60 India Cholera Vaccine Market, 2018 - 2030 (USD Million)
Fig. 61 Australia Country Dynamics
Fig. 62 Australia Cholera Vaccine Market, 2018 - 2030 (USD Million)
Fig. 63 South Korea Country Dynamics
Fig. 64 South Korea Cholera Vaccine Market, 2018 - 2030 (USD Million)
Fig. 65 Thailand Country Dynamics
Fig. 66 Thailand Cholera Vaccine Market, 2018 - 2030 (USD Million)
Fig. 67 Latin America Cholera Vaccine Market, 2018 - 2030 (USD Million)
Fig. 68 Brazil Country Dynamics
Fig. 69 Brazil Cholera Vaccine Market, 2018 - 2030 (USD Million)
Fig. 70 Argentina Country Dynamics
Fig. 71 Argentina Cholera Vaccine Market, 2018 - 2030 (USD Million)
Fig. 72 MEA Cholera Vaccine Market, 2018 - 2030 (USD Million)
Fig. 73 South Africa Country Dynamics
Fig. 74 South Africa Cholera Vaccine Market, 2018 - 2030 (USD Million)
Fig. 75 Saudi Arabia Country Dynamics
Fig. 76 Saudi Arabia Cholera Vaccine Market, 2018 - 2030 (USD Million)
Fig. 77 UAE Country Dynamics
Fig. 78 UAE Cholera Vaccine Market, 2018 - 2030 (USD Million)
Fig. 79 Kuwait Country Dynamics
Fig. 80 Kuwait Cholera Vaccine Market, 2018 - 2030 (USD Million)
Fig. 81 Company Categorization
Fig. 82 Company Market Position Analysis
Fig. 83 Strategic Framework

Companies Mentioned

  • Valneva SE
  • Sanofi S.A.
  • Emergent BioSolutions Inc.
  • PaxVax Inc.
  • EuBiologics Co., Ltd.
  • Shantha Biotechnics Limited
  • Hilleman Laboratories
  • Astellas Pharma Inc.
  • Incepta Vaccine Ltd.
  • Vabiotech

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages100
PublishedNovember 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 93.9 Million
Forecasted Market Value ( USD ) by 2030 $ 163.4 Million
Compound Annual Growth Rate10.0%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Cholera Vaccines Market by Type, Method of Administration, End User, Age Group - Global Forecast 2025-2030 - Product Image

Cholera Vaccines Market by Type, Method of Administration, End User, Age Group - Global Forecast 2025-2030

  • Report
  • 199 Pages
  • Global
From
Cholera Vaccines Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030 - Product Image

Cholera Vaccines Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030

  • Report
  • 117 Pages
  • Global
From
Cholera Vaccines Market Report by Vaccine Type, Product, End User, and Region 2024-2032 - Product Image

Cholera Vaccines Market Report by Vaccine Type, Product, End User, and Region 2024-2032

  • Report
  • 138 Pages
  • Global
From
Cholera Vaccines Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028) - Product Image

Cholera Vaccines Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)

  • Report
  • 114 Pages
  • Global
From
Cholera Vaccines Market Report and Forecast 2023-2031 - Product Image

Cholera Vaccines Market Report and Forecast 2023-2031

  • Report
  • 147 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.